Comparison · Updated
Arch vs Enzyme Finance: Which Is Better for You in 2026?
Arch is the more approachable option for people seeking managed crypto index products and Latin American bank withdrawals. Enzyme is better suited to users or businesses exploring tokenized funds and on-chain strategies, but both require careful checks on fees, terms and risk.
Enzyme Finance
Indexes
TVL $76.4M · 3 chains
Side by side
Arch vs Enzyme Finance at a glance
| Arch | Enzyme Finance | |
|---|---|---|
| Category | Crypto investment platform with index-style products | Infrastructure for tokenized funds and on-chain strategies |
| Chains | Ethereum, Polygon | Ethereum, Polygon, Arbitrum |
| TVL | Smaller reported TVL; snapshot date not published | Higher reported TVL; snapshot date not published |
| Token | No token listed | MLN |
| Fees | A clear fee schedule is not published | No standard platform-wide fee schedule; costs vary by product |
| Security and audits | Two audits listed; scope and findings unspecified | Two audits recorded; Enzyme says it is SOC 2 certified |
| Ease of use | Account-based investing process described as straightforward | More complex; product, fund and strategy determine the process |
| Standout feature | Bitcoin exposure, diversified crypto products and some Latin American bank withdrawals | Onyx, Blue, Myso and Vaults for different fund and strategy needs |
| Regulatory status | CMF registration process in progress; not a completed registration | No platform-wide licence published |
| Best for | People seeking managed crypto exposure and supported bank withdrawals in five Latin American countries | Fund managers, institutions and crypto users seeking tokenized funds or on-chain strategies |
Which is safer, Arch or Enzyme?
Neither is clearly safer for every user; Arch and Enzyme both involve product-specific risks, and their security signals do not guarantee that funds are protected. Arch says customer assets are separated from the company and other clients, and that customers retain control, but it does not explain the custody arrangements or what happens if the company fails. It lists two audits without publishing their scope, dates or findings. Arch also says its Chilean CMF registration process is in progress.
Enzyme says it is SOC 2 certified and that its Vault infrastructure has undergone smart-contract audits; two audits are recorded for the protocol. Those controls do not prevent investment losses or eliminate contract risk. Enzyme does not publish a platform-wide licence, and control, custody and withdrawal conditions can vary by fund or product. Check the actual audit reports and the terms of the specific investment. For either platform, understand who controls assets and strategy settings, how withdrawals work, and what could happen if a provider or contract fails.
Which is cheaper, Arch or Enzyme?
Neither can be called cheaper based on a single published price list, because neither provides standard fees across all its products. Arch does not publish a clear schedule for investment, trading, spreads or withdrawals. Its bank-transfer options have stated minimums, but those are not a complete fee breakdown. Ask Arch for the charges, exchange rates and any product-level costs in writing before depositing.
Enzyme’s charges depend on the product and arrangement. A fund or strategy may charge management, performance or other fees, and blockchain transactions can require gas fees paid to the network. Enzyme does not publish one price list covering Onyx, Blue, Myso and every vault. Compare the total cost for the exact product you plan to use, including deposits, trades and withdrawals. A low or undisclosed platform charge does not mean the investment itself is inexpensive.
Which is easier for a beginner?
Arch is likely easier for a beginner seeking managed crypto exposure, while Enzyme is more complex because it is infrastructure for different funds and strategies rather than one simple investment account. Arch describes creating an account, choosing a product and selecting a payment method. It offers Bitcoin-focused and diversified crypto products, although users still need to understand each product’s holdings, fees and risk. Its account process may be simpler, but it does not make crypto investing low-risk.
Enzyme users first need to identify the right product or fund and then understand its rules. A decentralized vault may involve connecting a wallet, using an accepted asset and paying blockchain gas. Onyx is aimed at businesses issuing tokenized products, while Blue and Vaults concern strategy management and Myso concerns options. That variety can be useful to experienced users, but it adds choices and product-specific terms. A beginner should not deposit into an Enzyme fund without understanding who manages it, what it can do and when withdrawals are allowed.
What can Arch do that Enzyme cannot, and vice versa?
Arch’s main distinction is managed crypto exposure with Bitcoin and diversified products, plus bank withdrawals in five Latin American countries; Enzyme’s main distinction is its toolkit for different tokenized funds and on-chain strategies. Arch is not simply an exchange or a token of its own. Its products can include Bitcoin exposure, diversified crypto and other Web3 strategies, and the company describes bank withdrawals in Chile, Colombia, Mexico, Argentina and Peru.
Enzyme offers separate products for different jobs: Onyx supports businesses issuing and administering tokenized funds and financial instruments; Blue supports decentralized strategy management; Myso offers on-chain options such as covered calls and cash-secured puts; and Vaults support strategy management through smart contracts. Arch may better match someone seeking a managed investment product and eligible local bank withdrawals. Enzyme may better match a fund manager or user looking for specific on-chain fund infrastructure. Neither feature set replaces due diligence on an individual product.
Which should you choose?
Arch may suit users who want managed crypto products and can use its supported regional bank withdrawals; Enzyme may suit people seeking tokenized funds, fund-management tools or on-chain strategies. Before choosing either, first identify whether the product is intended for individual investing, fund issuance or decentralized strategy use. Then check the underlying assets, who manages the strategy, how custody works and whether access is available in your location.
Arch says its CMF registration process is still in progress, and the company says it is not a registered investment adviser, broker or dealer. Enzyme does not publish a platform-wide licence; compliance tools on a product do not establish regulatory approval. For both, obtain written fee and withdrawal terms. Arch does not publish a clear full fee schedule, while Enzyme rules and costs vary by product. Do not treat either platform’s audits, operating history or security claims as a guarantee against losses.
Verdict: Arch or Enzyme Finance?
Arch is the more direct fit if you want managed crypto exposure, particularly Bitcoin or diversified products, and can use its supported Latin American bank withdrawals. Enzyme is the better fit for fund managers, institutions and crypto users seeking tokenized funds, options or on-chain strategy tools. Neither is an obvious low-risk choice: fees and product terms need checking, and both have investment or technical risks. Choose Arch if its products and withdrawal options match your needs. Choose Enzyme if you need its specific fund or strategy infrastructure.
Frequently asked questions
Can I invest in Bitcoin with Arch or Enzyme?
Arch says it offers Bitcoin-focused products and diversified cryptocurrency exposure, while Enzyme provides infrastructure for funds and strategies that may invest in different assets. Neither removes the risk of losing money, so review the specific product’s strategy, holdings and terms.
Which platform has lower fees?
Neither publishes one standard fee schedule covering every product. Arch’s investment, trading and withdrawal fees are unclear, while Enzyme costs can depend on the product, fund manager and blockchain gas fees; get the full charges before committing funds.
Do Arch and Enzyme require KYC?
KYC requirements depend on the Enzyme product and its issuer or manager; Enzyme does not set one platform-wide rule. Arch requires identity verification for bank withdrawals if it has not already been completed, and users should check other product requirements directly.
Which platform supports bank withdrawals?
Arch says it supports bank withdrawals in Chile, Colombia, Mexico, Argentina and Peru. Enzyme withdrawals depend on the specific fund or vault, its accepted assets and its rules; it does not publish a single platform-wide withdrawal schedule.